Literature DB >> 7568041

Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats.

B K Lipska1, D R Weinberger.   

Abstract

We explored how two independent variables, one genetic (i.e., specific rat strains) and another environmental (i.e., a developmental excitotoxic hippocampal lesion), contribute to phenotypic variation. Sprague-Dawley (SD), Fischer 344 (F344), and Lewis rats underwent two grades of neonatal excitotoxic damage: small and large ventral hippocampal (SVH and LVH) lesions. Locomotion was tested before puberty [postnatal day 35 (P35)] and after puberty (P56) following exposure to a novel environment or administration of amphetamine. The behavioral effects were strain- and lesion-specific. As shown previously, SD rats with LVH lesions displayed enhanced spontaneous and amphetamine-induced locomotion as compared with controls at P56, but not at P35. SVH lesions in SD rats had no effect at any age. In F344 rats with LVH lesions, enhanced spontaneous and amphetamine-induced locomotion appeared early (P35) and was exaggerated at P56. SVH lesions in F344 rats resulted in a pattern of effects analogous to LVH lesions in SD rats--i.e., postpubertal onset of hyperlocomotion (P56). In Lewis rats, LVH lesions had no significant effect on novelty- or amphetamine-induced locomotion at any age. These data show that the degree of genetic predisposition and the extent of early induced hippocampal defect contribute to the particular pattern of behavioral outcome. These results may have implications for modeling interactions of genetic and environmental factors involved in schizophrenia, a disorder characterized by phenotypic heterogeneity, genetic predisposition, a developmental hippocampal abnormality, and vulnerability to environmental stress.

Entities:  

Mesh:

Year:  1995        PMID: 7568041      PMCID: PMC41076          DOI: 10.1073/pnas.92.19.8906

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Drugs and reinforcement mechanisms: a critical review of the catecholamine theory.

Authors:  H C Fibiger
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

2.  Brain 5-hydroxytryptamine correlates of behavior in rats: strain and sex variability.

Authors:  J A Rosecrans; M D Schechter
Journal:  Physiol Behav       Date:  1972-03

Review 3.  Cellular and molecular mechanisms of drug dependence.

Authors:  G F Koob; F E Bloom
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

4.  Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system.

Authors:  M A Bozarth
Journal:  Behav Brain Res       Date:  1986-11       Impact factor: 3.332

5.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.

Authors:  E M Sternberg; J M Hill; G P Chrousos; T Kamilaris; S J Listwak; P W Gold; R L Wilder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex.

Authors:  E D Abercrombie; K A Keefe; D S DiFrischia; M J Zigmond
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

7.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

8.  Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains.

Authors:  T Suzuki; F R George; R A Meisch
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

9.  Genetic control of collagen-induced arthritis in rats: the immune response to type II collagen among susceptible and resistant strains and evidence for multiple gene control.

Authors:  M M Griffiths; C W DeWitt
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Neuroendocrine, biogenic amine and behavioral responsiveness to a repeated foot-shock-induced analgesia (FSIA) stressor in Sprague-Dawley (CD) and Fischer-344 (CDF) rats.

Authors:  J A Rosecrans; S E Robinson; J H Johnson; D J Mokler; J S Hong
Journal:  Brain Res       Date:  1986-09-10       Impact factor: 3.252

View more
  25 in total

Review 1.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

2.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

3.  A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Authors:  Barbara K. Lipska; Daniel R. Weinberger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

4.  Quantitative trait locus analysis identifies rat genomic regions related to amphetamine-induced locomotion and Galpha(i3) levels in nucleus accumbens.

Authors:  Marc N Potenza; Edward S Brodkin; Bao-Zhu Yang; Shari G Birnbaum; Eric J Nestler; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2008-01-23       Impact factor: 7.853

5.  Animal models of gene-environment interactions in schizophrenia.

Authors:  Yavuz Ayhan; Akira Sawa; Christopher A Ross; Mikhail V Pletnikov
Journal:  Behav Brain Res       Date:  2009-04-18       Impact factor: 3.332

6.  Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder.

Authors:  Brendan A Rich; Deborah T Vinton; Roxann Roberson-Nay; Rebecca E Hommer; Lisa H Berghorst; Erin B McClure; Stephen J Fromm; Daniel S Pine; Ellen Leibenluft
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

7.  Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

Authors:  Neil M Richtand; Benjamin Taylor; Jeffrey A Welge; Rebecca Ahlbrand; Michelle M Ostrander; Jeffrey Burr; Scott Hayes; Lique M Coolen; Laurel M Pritchard; Aaron Logue; James P Herman; Robert K McNamara
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

8.  Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat.

Authors:  Rainer Wolf; Henrik Dobrowolny; Sven Nullmeier; Bernhard Bogerts; Herbert Schwegler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-30       Impact factor: 5.270

Review 9.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

10.  Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.

Authors:  Axel Becker; Gerd Geisslinger; Radovan Murín; Gisela Grecksch; Volker Höllt; Andreas Zimmer; Helmut Schröder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.